The silver bullet for cancer prevention: Chemopreventive effects of carotenoids

BioMedicine (Netherlands)

Volumn 2, Issue 3, 2012, Pages 117-121

  Tang, Feng Yao ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer; Carotenoids; Invasion; Metastasis; Proliferation

Indexed keywords

ASTAXANTHIN; BETA CAROTENE; BETA CATENIN; BETA CRYPTOXANTHIN; CAROTENOID; CASPASE 3; FUCOXANTHIN; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; UVOMORULIN; XANTHOPHYLL; ZEAXANTHIN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REPRESSION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR VOLUME;

EID: 84866514150     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2012.06.004     Document Type: Review

References (41)

1. Seshadri T.R. Biochemistry of natural pigments; (exclusive of haeme pigments and carotenoids). Annu Rev Biochem 1951, 20:487-512.
2. Bartley G.E., Scolnik P.A. Plant carotenoids: pigments for photoprotection, visual attraction, and human health. Plant Cell 1995, 7:1027-1038.
3. Handelman G.J. The evolving role of carotenoids in human biochemistry. Nutrition 2001, 17:818-822.
4. Stahl W., Sies H. Bioactivity and protective effects of natural carotenoids. Biochemica et Biophysica Acta 2005, 1740:101-107.
5. Johnson E.J. The role of carotenoids in human health. Nutr Clin Care 2002, 5:56-65.
6. Rao A.V., Rao L.G. Carotenoids and human health. Pharmacol Res 2007, 55:207-216.
7. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
8. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
9. Samuels Y., Velculescu V.E. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 2004, 3:1221-1224.
10. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304:554.
11. Morgensztern D., McLeod H.L. PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 2005, 16:797-803.
12. Tominaga K., Higuchi K., Sasaki E., Suto R., Watanabe T., Fujiwara Y., et al. Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells. Aliment Pharmacol Ther 2004, 20(Suppl. 1):143-150.
13. Soslow R.A., Dannenberg A.J., Rush D., Woerner B.M., Khan K.N., Masferrer J., et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000, 89:2637-2645.
14. Conacci-Sorrell M., Simcha I., Ben-Yedidia T., Blechman J., Savagner P., Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 2003, 163:847-857.
15. Li Q., Mattingly R.R. Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells. Neoplasia 2008, 10:1444-1458.
16. Tang F.Y., Chiang E.P., Chung J.G., Lee H.Z., Hsu C.Y. S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer. J Nutr Biochem 2009, 20:1013-1020.
17. Ogata Y., Miura K., Ohkita A., Nagase H., Shirouzu K. Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma. Kurume Med J 2001, 48:211-218.
18. Westermarck J., Kähäri V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999, 13:781-792.
19. Takeha S., Fujiyama Y., Bamba T., Sorsa T., Nagura H., Ohtani H. Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect. Jpn J Cancer Res 1997, 88:72-81.
20. Zuzga D.S., Gibbons A.V., Li P., Lubbe W.J., Chervoneva I., Pitari G.M. Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis. Clin Transl Sci 2008, 1:136-141.
21. Aparicio T., Lehy T. Matrix metalloproteases in digestive pathology. Gastroenterol Clin Biol 1999, 23:330-341. [Article in French].
22. Aparicio T., Kermorgant S., Dessirier V., Lewin M.J., Lehy T. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis 1999, 20:1445-1451.
23. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994, 330:1029-1035.
24. La Vecchia C. Mediterranean epidemiological evidence on tomatoes and the prevention of digestive-tract cancers. Proc Soc Exp Biol Med 1998, 218:125-128.
25. La Vecchia C. Association between Mediterranean dietary patterns and cancer risk. Nutr Rev 2009, 67(Suppl. 1):S126-S129.
26. Liu C., Lian F., Smith D.E., Russell R.M., Wang X.D. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 2003, 63:3138-3144.
27. Tang F.Y., Shih C.J., Cheng L.H., Ho H.J., Chen H.J. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Mol Nutr Food Res 2008, 52:646-654.
28. Tang F.Y., Pai M.H., Wang X.D. Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. J Agric Food Chem 2011, 59:9011-9021.
29. Tang F.Y., Cho H.J., Pai M.H., Chen Y.H. Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J Nutr Biochem 2009, 20:426-434.
30. Huang C.S., Liao J.W., Hu M.L. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J Nutr 2008, 138:538-543.
31. Huang C.S., Fan Y.E., Lin C.Y., Hu M.L. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J Nutr Biochem 2007, 18:449-456.
32. Lian F., Smith D.E., Ernst H., Russell R.M., Wang X.D. Apo-10'-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007, 28:1567-1574.
33. Liu C.L., Huang Y.S., Hosokawa M., Miyashita K., Hu M.L. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chem Biol Interact 2009, 182:165-172.
34. Liu C.L., Lim Y.P., Hu M.L. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells. Mar Drugs 2012, 10:242-257.
35. Yu R.X., Hu X.M., Xu S.Q., Jiang Z.J., Yang W. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway. Eur J Pharmacol 2011, 657:10-19.
36. Liu C., Bronson R.T., Russell R.M., Wang X.D. β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets. Cancer Prev Res (Phila) 2011, 4:1255-1266.
37. Nakao R., Nelson O.L., Park J.S., Mathison B.D., Thompson P.A., Chew B.P. Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice. Anticancer Res 2010, 30:2171-2175.
38. Nagendraprabhu P., Sudhandiran G. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs 2011, 29:207-224.
39. Le Marchand L., Hankin J.H., Bach F., Kolonel L.N., Wilkens L.R., Stacewicz-Sapuntzakis M., et al. An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 1995, 63:18-23.
40. Nkondjock A., Ghadirian P. Dietary carotenoids and risk of colon cancer: case-control study. Int J Cancer 2004, 110:110-116.
41. Reynoso-Camacho R., González-Jasso E., Ferriz-Martínez R., Villalón-Corona B., Loarca-Piña G.F., Salgado L.M., et al. Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and β-catenin proteins. Nutr Cancer 2011, 63:39-45.